The role of apoptosis in cancer development and treatment response
Top Cited Papers
- 1 March 2005
- journal article
- Published by Springer Nature in Nature Reviews Cancer
- Vol. 5 (3), 231-237
- https://doi.org/10.1038/nrc1560
Abstract
The inactivation of programmed cell death, or apoptosis, is central to the development of cancer. This disabling of apoptotic responses might be a major contributor both to treatment resistance and to the observation that, in many tumours, apoptosis is not the main mechanism for the death of cancer cells in response to common treatment regimens. Importantly, this suggests that other modes of cell death are involved in the response to therapy.Keywords
This publication has 52 references indexed in Scilit:
- The role of p53-mediated apoptosis as a crucial anti-tumor response to genomic instability: lessons from mouse modelsMutation Research, 2005
- Cell death by mitotic catastrophe: a molecular definitionOncogene, 2004
- Disruption of the Fanconi anemia–BRCA pathway in cisplatin-sensitive ovarian tumorsNature Medicine, 2003
- The role of p53 in determining sensitivity to radiotherapyNature Reviews Cancer, 2003
- Live or let die: the cell's response to p53Nature Reviews Cancer, 2002
- The Hallmarks of CancerCell, 2000
- Disruption of p53 in human cancer cells alters the responses to therapeutic agentsJournal of Clinical Investigation, 1999
- Transgenic mice with p53-responsive lacZ: p53activity varies dramatically during normal development and determines radiation and drug sensitivity invivoThe EMBO Journal, 1997
- p53 Status and the Efficacy of Cancer Therapy in VivoScience, 1994
- p53 is required for radiation-induced apoptosis in mouse thymocytesNature, 1993